Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/154517
Full metadata record
DC FieldValueLanguage
dc.creatorMarques, J-
dc.creatorDuarte-Ramos, F-
dc.creatorFerreira, MB-
dc.creatorLima, R-
dc.creatorLopes, C-
dc.creatorSokolova, A-
dc.creatorTonin, FS-
dc.creatorLoureiro, CC-
dc.creatorPortuguese ROSA Group-
dc.date.accessioned2023-11-14T12:12:01Z-
dc.date.available2023-11-14T12:12:01Z-
dc.date.issued2023-
dc.identifier.issn2531-0437-
dc.identifier.urihttps://hdl.handle.net/10216/154517-
dc.description.abstractn/a-
dc.language.isoeng-
dc.publisherElsevier-
dc.relation.ispartofPulmonology. 2023 Nov-Dec;29(6):555-563. doi: 10.1016/j.pulmoe.2023.07.003. Epub 2023 Aug 3.-
dc.rightsopenAccess-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.titleOptimizing the use of systemic corticosteroids in severe asthma (ROSA II project): a national Delphi consensus study-
dc.typeOutra Publicação em Revista Científica Internacional-
dc.contributor.uportoInstituto de Saúde Pública da Universidade do Porto-
dc.identifier.doi10.1016/j.pulmoe.2023.07.003-
dc.relation.publisherversionhttps://www.sciencedirect.com/science/article/pii/S2531043723001289?via%3Dihub-
Appears in Collections:ISPUP - Outra Publicação em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
marques-p2023.pdf715.57 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons